Poulvac Procerta HVT-IBD
بولفاك بروسيرتا إتش في تي - آي بي دي
Poulvac Procerta HVT-IBD is a frozen, cell-associated recombinant vector vaccine containing a serotype 3 turkey herpesvirus (HVT) expressing the VP2 protective gene of Infectious Bursal Disease Virus (IBDV). Effective for vaccination of 18- to 19-day-old embryonated chicken eggs (in ovo) or healthy 1-day-old chicks against standard IBDV and Marek's disease. Duration of immunity is at least 63 days.
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
5 x 2,000-dose and 5 x 4,000-dose ampoules stored in liquid nitrogen
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Poultry | 0.05 mL (in ovo) or 0.2 mL (subcutaneous) | In ovo or Subcutaneous (SC) | Single application |
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| Poultry | 21 | 21 |
Indications
-
Aid in the prevention of Marek's disease and infectious bursal disease (Gumboro) in healthy chickens.
-
Effective duration of immunity of at least 63 days against standard IBDV.
Contraindications
-
Do not use if ampoule has thawed prior to planned reconstitution.
Precautions
-
Operators must wear safety glasses and cryogenic protective gloves when handling liquid nitrogen.
-
Use within 2 hours of dilution.
Side Effects
-
None observed under proper in ovo or subcutaneous administration.
Images
Documents
-
Download
Poulvac Procerta HVT-IBD Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
No data available
Information has not been added yet.
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.